Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemotrizinol Dermal Safety Study
NCT05260359Phase 2Completed
- Sponsor
- DSM-Firmenich
- Start
- Feb 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bemcentinib in sunburn, sponsored by DSM-Firmenich. Started Feb 2022; status: completed.
02
Drugs
bemcentinib
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT05260359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05260359.